If you are living with depression, anxiety, PTSD, or a substance use disorder that has not responded to conventional treatment, Brightiva may offer a path forward. Ask your current provider to join The Brightiva Network.
Brightiva is a proprietary three-component ketamine formulation developed by Dr. Paul Hebig, a board-certified psychiatrist with over 22 years of clinical experience. Unlike other ketamine treatments, Brightiva combines ketamine with two complementary components specifically chosen to extend and enhance its therapeutic effects. It was also designed to be affordable for patients who previously had no realistic path to ketamine treatment. Based on Dr. Hebig’s direct observation treating thousands of patients, Brightiva has produced meaningful relief for patients whose conditions had not responded to prior treatment.
Your provider will determine whether Brightiva is clinically appropriate for your individual situation.
For patients with specific contraindications to one or more components of the Brightiva formulation, an alternative ketamine-only formulation may be available. Speak with your provider about whether this option is appropriate for you to use with the treatment protocol..
Brightiva is a dissolvable tablet administered under or on the tongue in your provider’s office, under direct clinical supervision. You will remain at the clinic for a minimum of 90 minutes following administration. Your vital signs are monitored before and after the treatment.
Treatment follows a structured protocol that includes an active treatment phase and may include a maintenance phase. Based on Dr. Hebig’s experience, many patients have reported meaningful improvement within the first two weeks.
You will need to arrange transportation home after each session. Driving on the day of treatment is not permitted.
Brightiva is available only through licensed providers who are members of The Brightiva Network.
If you are working with a psychiatrist, psychiatric NP, PA, or other licensed healthcare prescriber, speak with them about Brightiva and ask whether they are a Network member. If they are not yet a member, encourage them to apply at www.Brightiva.com.
Brightiva is a compounded medication prescribed off-label by licensed providers. It does not carry an FDA indication or approval for psychiatric conditions. Your provider will determine whether it is appropriate for your individual situation based on your history and clinical needs.
Brightiva is available in all U.S. states except Illinois, Mississippi, Hawaii, and Washington D.C. Please speak with your prescriber to confirm availability in your area.
Based on Dr. Hebig's clinical experience, many patients have reported meaningful improvement within the first two weeks of treatment. Some have experienced relief after a single session. Individual results vary and your provider will monitor your progress throughout the protocol.
If you have a known allergy or prior adverse reaction to ketamine, dextromethorphan, or fluoxetine, speak with your provider before starting treatment. An alternative ketamine-only formulation may be available for patients with contraindications to dextromethorphan or fluoxetine.
No. Your insurance will not pay for the compounded medication, yet your encounter with your provider and your time in the treatment clinic are usually covered similarly to any other visit with your provider. Brighitva is affordable for most patients. Talk directly with your provider for the specific cost per treatment. In Dr. Hebig’s experience, most patients wish they would have started treatment years ago and find the cost very reasonable.
No. Driving on the day of treatment is not permitted. You will need to arrange transportation home after each session.
Your provider will conduct a full clinical assessment before recommending Brightiva. It is not appropriate for patients with certain conditions including active mania or psychosis, pregnancy, or poorly controlled high blood pressure. Your provider will discuss all available options with you.
Speak with your current psychiatrist, psychiatric NP, PA, or prescriber about Brightiva. If they are not yet a Network member, encourage them to apply.